Activin and Inhibin

iMDK is a potent PI3K inhibitor and inhibits the growth factor MDK (also known as midkine or MK). iMDK suppresses non-small cell lung cancer (NSCLC) cooperatively with A MEK inhibitor without harming normal cells and mice.In VitroiMDK (50–500 nM)

iMDK is a potent PI3K inhibitor and inhibits the growth factor MDK (also known as midkine or MK). iMDK suppresses non-small cell lung cancer (NSCLC) cooperatively with A MEK inhibitor without harming normal cells and mice.In VitroiMDK (50–500 nM)

iMDK is a potent PI3K inhibitor and inhibits the growth factor MDK (also known as midkine or MK). iMDK suppresses non-small cell lung cancer (NSCLC) cooperatively with A MEK inhibitor without harming normal cells and mice.In VitroiMDK (50–500 nM)

iMDK quarterhydrate is a potent PI3K inhibitor and inhibits the growth factor MDK (also known as midkine or MK). iMDK quarterhydrate suppresses non-small cell lung cancer (NSCLC) cooperatively with A MEK inhibitor without harming normal cells and

Product DescriptionImiquimod (R 837) is an immune response modifier that acts as a toll-like receptor 7 agonist.A TLR7 activator and angiogenesis inhibitor.Product ApplicationImiquimod is a caspase 3 activator which acts as an immunomodulator and

Product DescriptionImiquimod (R 837) is an immune response modifier that acts as a toll-like receptor 7 agonist.A TLR7 activator and angiogenesis inhibitor.Product ApplicationImiquimod is a caspase 3 activator which acts as an immunomodulator and

Product DescriptionImiquimod (R 837) is an immune response modifier that acts as a toll-like receptor 7 agonist.A TLR7 activator and angiogenesis inhibitor.Product ApplicationImiquimod is a caspase 3 activator which acts as an immunomodulator and

Product DescriptionImiquimod (R 837) is an immune response modifier that acts as a toll-like receptor 7 agonist.A TLR7 activator and angiogenesis inhibitor.Product ApplicationImiquimod is a caspase 3 activator which acts as an immunomodulator and

Product DescriptionImiquimod (R 837) is an immune response modifier that acts as a toll-like receptor 7 agonist.A TLR7 activator and angiogenesis inhibitor.Product ApplicationImiquimod is a caspase 3 activator which acts as an immunomodulator and

Product DescriptionImiquimod (R 837) is an immune response modifier that acts as a toll-like receptor 7 agonist.A TLR7 activator and angiogenesis inhibitor.Product ApplicationImiquimod is a caspase 3 activator which acts as an immunomodulator and

Product DescriptionImiquimod (R 837) is an immune response modifier that acts as a toll-like receptor 7 agonist.A TLR7 activator and angiogenesis inhibitor.Product ApplicationImiquimod is a caspase 3 activator which acts as an immunomodulator and

Imirestat (AL 1576) is an aldose reductase inhibitor, used for the treatment of diabetes.In VivoImirestat (1 mg/kg) improves nerve conduction velocity but is without effect upon the resistance to hypoxic conduction blockade or the deficit in